Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ABCB5-positive mesenchymal stromal cells (MSCs) are a subpopulation of skin-derived MSCs characterized by ABCB5 expression. They promote wound healing through immunomodulatory and anti-inflammatory mechanisms, including IL-1RA secretion and macrophage polarization, making them potential therapeutic agents for chronic wounds and RDEB.
Immunomodulation via IL-1RA secretion, macrophage polarization (M1 to M2 shift), suppression of TNF-alpha secretion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Wound healing promotion via ABCB5-positive mesenchymal stromal cells (ABCB5+ MSCs).